EVP Robertson sells 122,479 shares at $7.96–$8.00 (blended $7.96), reducing stake by -19.4% to 509,276 shares
Robertson Stephen P., EVP and General Counsel at Aurinia Pharmaceuticals, executed 2 separate sales totaling 122,479 shares for $975,223.44 across March 3–4, 2025, at prices of $8.00 and $7.92. The sale reduced his holdings by -19.4% from 631,755 to 509,276 shares. The stock currently trades at $8.08, slightly above his transaction average of $7.96, and is -22.6% from its 52-week high of $10.44, suggesting the sales occurred near the lower end of recent range. Aurinia shows strong fundamentals with annual revenue growth of +34.0%, net income of $14,350,000.00, and a P/E of 17.96, indicating profitable operations without obvious distress; the sale represents a material reduction in executive stake size, warranting investor attention to understand the motivation behind the divestiture.